Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/115597
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNeumann, Joachim-
dc.contributor.authorDhein, Stefan-
dc.contributor.authorKirchhefer, Uwe-
dc.contributor.authorHofmann, Britt-
dc.contributor.authorGergs, Ulrich-
dc.date.accessioned2024-04-09T06:17:28Z-
dc.date.available2024-04-09T06:17:28Z-
dc.date.issued2024-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/117550-
dc.identifier.urihttp://dx.doi.org/10.25673/115597-
dc.description.abstractHallucinogenic drugs are used because they have effects on the central nervous system. Their hallucinogenic effects probably occur via stimulation of serotonin receptors, namely, 5-HT2A-serotonin receptors in the brain. However, a close study reveals that they also act on the heart, possibly increasing the force of contraction and beating rate and may lead to arrhythmias. Here, we will review the inotropic and chronotropic actions of bufotenin, psilocin, psilocybin, lysergic acid diethylamide (LSD), ergotamine, ergometrine, N,N-dimethyltryptamine, and 5-methoxy-N,N-dimethyltryptamine in the human heart.eng
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc610-
dc.titleEffects of hallucinogenic drugs on the human hearteng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleFrontiers in pharmacology-
local.bibliographicCitation.volume15-
local.bibliographicCitation.publishernameFrontiers Media-
local.bibliographicCitation.publisherplaceLausanne-
local.bibliographicCitation.doi10.3389/fphar.2024.1334218-
local.openaccesstrue-
dc.identifier.ppn1884717187-
cbs.publication.displayform2024-
local.bibliographicCitation.year2024-
cbs.sru.importDate2024-04-09T06:16:54Z-
local.bibliographicCitationEnthalten in Frontiers in pharmacology - Lausanne : Frontiers Media, 2010-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
fphar-15-1334218.pdf1.39 MBAdobe PDFThumbnail
View/Open